Tianeptine (Coaxil) is a prescription atypical antidepressant widely used for the treatment of major depressive disorder (MDD) and anxiety-related conditions. Unlike conventional antidepressants such as SSRIs or SNRIs, tianeptine works through a unique mechanism, enhancing serotonin reuptake while regulating glutamate activity in the brain. This dual action supports mood stabilization, cognitive function, and emotional resilience.
Clinically, tianeptine is known for its rapid onset of action, minimal sexual side effects, and low sedative properties when taken at therapeutic doses. It is commonly prescribed in Europe, Asia, and parts of Latin America under brand names like Coaxil, Stablon, and Tatinol. Research also highlights its role in reducing stress-induced neuronal damage and improving neuroplasticity.
However, due to its μ-opioid receptor activity, misuse at high doses may lead to dependence or withdrawal symptoms. As a result, tianeptine is regulated or restricted in several countries and should only be used under medical supervision.
Recommended Authorities
Authoritative medical sources (e.g. pharmacology journals)
